Earnings call was expected. News of 1 year ahead Is huge. However this will linger at these prices until big news of revenues comes in. We are very close but it will happen. With that we have the potential to become a very successful company and a buyout candidate to larger medical companies . High risk with superb rewards if all goes to plan. So far it has .
News 
Market Data 
Discover 
